Charles River Laboratories Showcases End-to-End Oncology Capabilities at AACR 2023
10.04.2023 - Charles River Laboratories International, Inc. (NYSE: CRL) today announced that its team of oncology experts will attend the American Association for Cancer Research (AACR) Annual Meeting, with 19 scientific posters and a spotlight presentation to ... Seite 1
Steven Bronson Arif Khan Gemma Moiset Nicholas Ostrout Group Leader Advanced Modalities Navigating Cell Therapy Discovery
Source: wallstreet-online.de